Trial intelligence / Profile preview

Neuromuscular blockade effects on transpulmonary pressure and diaphragm activity in pediatric ARDS

NL-OMON23189Active, not recruiting

Sponsor
University Medical Center Groningen
Start
Mar 2017
Countries
1
01

Overview

Open-label, single-arm trial in Pediatric Acute Respiratory Distress Syndrome (PARDS), sponsored by University Medical Center Groningen. Primary endpoint: Transpulmonary pressure. Started Mar 2017; status: active, not recruiting.

02

Conditions

Pediatric Acute Respiratory Distress Syndrome (PARDS)

Beyond the preview

Go deeper on NL-OMON23189.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON23189.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call